A pharmacoeconomic evaluation of zuclopenthixol and resperidone in the treatment of schizophrenia. Economic and Health Policy Implications

A pharmacoeconomic evaluation of zuclopenthixol and resperidone in the treatment of schizophrenia. Economic and Health Policy Implications

2000

Hansen, H. | Francois, C. | Toumi, M. | Perilat, A. | Lancon, C. | Volume: , Issue: , Pages: ,